BSR has published an updated life-course guideline for the prescription and monitoring of conventional synthetic disease modifying anti-rheumatic drugs (csDMARDs).Find out more via our <a href='https://www.rheumatology.org.uk/news'>blog</a>. Join guideline working group Chair, Louise Mercer, and group members James Galloway, Katie Bechman, Akhila Kavirayani and Alan Davidson, in a roundtable discussion hosted by Prof Ernest Choy, Editor in Chief of Rheumatology to find out what is included in the publication and what has changed since the 2017 guideline was published. Find the video version of this episode on the BSR <a href='https://www.youtube.com/@RheumatologyUK'>YouTube channel</a>. Read the full guideline and download the handy infographic and audit tool <a href='https://www.rheumatology.org.uk/guidelines'>here</a>. Thanks for listening to Talking Rheumatology! Join the conversation on X using #TalkingRheum or tweet us <a href='https://x.com/RheumatologyUK'>@RheumatologyUK</a>. BSR is the UK's leading specialist medical society for rheumatology and MSK health professionals. To discover how we can support you in delivering the best care for your patients, <a href='https://www.rheumatology.org.uk/'>visit our website</a>.

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

Ep 31. GUIDELINES - BSR guideline for the prescription and monitoring of csDMARDs 2025

Talking Rheumatology

AI Chapters

AI Insights

Reviews